プロモーションスケジュール Genprex, Inc.
詳細なスケジュール
簡易グラフ
会社について Genprex, Inc.
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) that is in Phase 1/2 and 2 clinical trials to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002 for the treatment of type 1 diabetes, and GPX-003 for the treatment of type 2 diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.| IPO date | 2018-03-29 |
|---|---|
| ISIN | US3724461047 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.genprex.com |
| Цена ао | 2.74 |
| 1日あたりの価格変動: | -1.65% (0.89) |
|---|---|
| 週ごとの価格変動: | -3.81% (0.91) |
| 月ごとの料金変更: | -18.95% (1.08) |
| 3ヶ月間の価格変動: | +135.93% (0.371) |
| 半年間の価格変動: | -55.57% (1.97) |
| 年間の価格変動: | -90.49% (9.2) |
| 3年間の価格推移: | -36.57% (1.38) |
| 5年間の価格推移: | +222.75% (0.2712) |
| 10年間の価格推移: | 0% (0.8753) |
| 年初からの価格変動: | -21.85% (1.12) |
|
|
過小評価
|
効率
|
|||||||||||||||||||||||||||||||||||||
配当金
|
義務
|
成長の衝動
|
|||||||||||||||||||||||||||||||||||||
| 機関 | 音量 | 共有, % |
|---|---|---|
| Vanguard Group Inc | 45665 | 2.39 |
| Advisory Services Network, LLC | 17185 | 0.9 |
| CVI Holdings, LLC | 15456 | 0.81 |
| Geode Capital Management, LLC | 12321 | 0.64 |
| Blackrock Inc. | 11392 | 0.6 |
| Renaissance Technologies, LLC | 8988 | 0.47 |
| Citadel Advisors Llc | 4780 | 0.25 |
| State Street Corporation | 4311 | 0.23 |
| Squarepoint Ops LLC | 2945 | 0.15 |
| Commonwealth Equity Services, LLC | 2683 | 0.14 |
| スーパーバイザー | 役職 | 支払い | 生年 |
|---|---|---|---|
| Mr. David M. Schloss | Senior Vice President of Human Resources | N/A | |
| Mr. Thomas C. Gallagher Esq. | Senior Vice President of Intellectual Property & Licensing | N/A | |
| Dr. Mark S. Berger M.D. | Chief Medical Officer | 528.16k | 1955 (70 年) |
| Mr. Ryan M. Confer M.S. | President, CEO, CFO & Director | 1982 (43 年) | |
| Dr. Suzanne Thornton-Jones Ph.D. | Senior Vice President of Regulatory Affairs & Quality | ||
| Dr. Jack A. Roth F.A.C.S., M.D. | Chairman of Scientific & Medical Advisory Board |
住所: United States, Austin. TX, 3300 Bee Cave Road - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.genprex.com
Webサイト: https://www.genprex.com
